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Mapping of electrical activity in intact sheep atrial preparation
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IHU LIRYC, Bordeaux, France
It is well-established that pulmonary vein (PV) ectopic activity is the
trigger for paroxysmal atrial fibrillation (AF). However, the role of electro-
physiological and structural heterogeneity in the genesis and maintenance of
AF following PV ectopy are still relatively unknown.
In this preliminary study, we report on an optical mapping study to deter-
mine the structure-function relationship and electrophysiolopgical heteroge-
neity in left atrial vs PV tissue. Optical mapping experiments were performed
in circumflex artery-perfused left atrial preparations from sheep. The atria
were paced on the endocardial surface (n=5) between 0.5 to 6Hz. Action
potential duration (APD) was measured from four different regions of interest
(ROI): LAAEN (left atrial appendage), LAREN (left atrial roof) and PVEN
(pulmonary veins ostium) on endocardial surface and from LAAEP (left atrial
appendage) on epicardial surface.
During pacing of the endocardium, no significant APD differences were
observed between the four ROIs, except at a basic cycle length of 400 msec
where the pulmonary vein region displays shorter action potentials than the
(LAAEN: 209.58±17.04 msec and PVEN: 184.23±14.19 msec, P<0.05). In
addition, preliminary results also show that AP forms are heterogenic. The
action potential upstroke is is slower in PVEN rather than in LAAEN.
In conclusion, our results indicate electrophysiological heterogeneity in the
intact sheep left atrium which may contribute to the mechanisms underlying
the genesis and maintenance of AF.
Abstract 0259 – Figure: Circumflex artery-perfused left atrial preparation
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Introduction: Left atrium (LA) structural remodeling associated with atrial
fibrillation (AF) contributes to recurrence after AF catheter ablation (CA).
Characterizing LA function may be useful to identify patients with higher risk
of recurrence and could guide ablation strategy in term of substrate modifica-
tion. We aimed to identify predictors of recurrence and atrial remodeling by
assessing LA and left ventricle (LV) deformation properties using two-dimen-
sional speckle-tracking imaging before and after AF CA.
Methods: 62 patients (age 54±10 years, 90% male) with AF (45 paroxysmal
(PAF), 17 persistent (PsAF)) underwent an echocardiography before CA, 3 and
6 months after CA to assess LA strain (S total (S-tot), positive peak (S-pos),
negative peak (S-neg)), LA strain rate (SR positive peak (SRs), early (SRe) and
late negative peak (SRa)) and LV strain (LV longitudinal and radial S).
Results: PsAF patients baseline had significantly larger LA volumes (41±8
vs 32±10 ml/m²), decreased S-tot (10±5 vs 20±6%; p<0.001), SR-LAs (0.6±0.2
vs 1±0.3 s-1; p<0.001) and LV strain (-12±3 vs -16±3%; p<0.001) compared to
PAF group. After 6 month follow-up, 69% of the patients remained in sinus
rhythm. Baseline LA active emptying, reservoir function and LA S-tot (13.2±6.2
vs 20.1±7%, p<0.001), S-neg (-7.2±3.5 vs –10.6±3.3%, p<0.009), SR-s
(0.71±0.3 vs 1.01±0.35 s-1, <0.004), SR-a (–0.89±0.56 vs -1.37±0.48 s-1, p<0.01)
and LV strain (-13.5±4.8 vs -17.1±3.5%, p<0.003) were significantly decreased
in patients with AF recurrence. At multivariate analysis, the unique independent
predictor of sinus rhythm maintenance was LA S-tot (HR 0.819 (0.685-0.979),
p=0.028). In the overall cohort, LA volumes decreased from baseline to 3 and
6 months but there was no significant change in LA S, LA SR nor LV strain. At
multivariate analysis, the unique independent predictor of LA reverse remod-
eling after CA was the duration of AF history (HR 0.84 (0.73-0.96), p=0.013).
Conclusions: Altered global LA and LV strain before CA is associated
with AF recurrence. Echocardiographic LA function characterization before
ablation procedures may be helpful to guide AF ablation strategy and drug
management after CA.
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Background: Atrial fibrillation (AF) is a major etiological factor of isch-
emic strokes (IS). Recent data suggested that subclinical, i.e. silent AF,
assessed at the acute phase of stroke by Continuous ECG Monitoring (CEM)
is frequent, and associated with a worse prognosis. The aim of our study was
to investigate the incidence and determinants of silent AF in patients with
acute IS.
Methods: All consecutive patients admitted on the stroke unit of CHU
DIJON for IS or TIA were prospectively enrolled from March to December
2012. Patients with a history of AF or who experienced symptomatic AF
during their hospital stay were excluded. Silent AF was assessed by CEM for
24h after admission and defined as at least 1 episode >30 sec without p waves,
and with irregular RR intervals. An echocardiography was performed at 2±1 d
to measure left ventricular ejection fraction (LVEF) and left auricular (LA)
dimensions.
Results: Among the 187 patients included, 19 (10%) developed silent AF.
Patients with silent AF were markedly older (76 vs. 66 years, p<0.002), with
lower creatinine levels (90 vs. 80 μmol/L, p=0.030) and were less often
smokers (5 vs. 41% p=0.058) than patients without silent AF. They also
showed a trend towards more frequent hypertension (79 vs. 58%, p=0.057)
and a recent history of infection (16 vs. 5%, p=0.082). There was no
difference for chronic treatments, NIHSS score on admission, maximal heart
rate (HR) or diabetes. By backward multivariate analysis, only age remained
an independent estimate of silent AF. For echocardiographic measurements,
patients with silent AF showed a trend towards a larger indexed LA volume
(37.4 vs. 30.8 ml/ m3), p=0.057) and LA diameter (23.2 vs. 20.8 mm/m²,
p=0.059); LVEF was similar for the two groups (59 vs. 59%, p=0.582).
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Conclusion: This study demonstrated that silent AF detected by CEM is
common and associated with older age. Further studies are needed to investi-
gate the interest of systematical screening for silent AF for secondary preven-
tion after ischemic stroke.
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Introduction: If the management of atrial fibrillation in its thromboembolic
component knows more adherences to recommendations, it should be noted
that the rhythmic component is experiencing a trend towards acceptance of the
AF at the expense of a restoration strategy sinus rhythm.
Purpose: To evaluate the effectiveness of the drug cardioversion or elec-
trical cardioversion in patients hospitalized in the cardiology department of
HMIMV Rabat.
Materials and Methods: This is a prospective study conducted over a
period of one year, including 45 patients with non-valvular AF, candidates for
chemical or electrical cardioversion. All our patients have undergone transtho-
racic echocardiography, sometimes supplemented with a transesophageal
echocardiography and an assessment of thyroid
Results: The average age of our patients was 52.7 years with a sex ratio
2/1. 25% of our patients had hypertensive heart disease, 8% ischemic heart
disease, 4% dilated cardiomyopathy and the rest had a healthy heart. The
average diameter of the left atrium was 41 cm with an average surface to
19 cm². 60% of our patients have undergone cardioversion by external shock,
and 40% of theme by injection of amiodarone or flecainide. The rate of res-
toration of sinus rhythm was 78%, with a recurrence rate at one month 19%.
The predictive factors of recurrence were an ancient atrial fibrillation, a large
left atrium and a score CHA2DS2-VASC ≥ 1.
Conclusion: This study, showing an acceptable level of restoration and
maintenance of sinus rhythm, confirms the interest of promoting a strategy of
rhythm control, subject to patient selection on predictors of success.
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Transmural APD heterogeneity is thought to play an important role in
homogeneous repolarization of the ventricles. Abnormal heterogeneity of
action potential duration (APD) in ventricles is known to contribute to
arrhythmogenesis. It has been shown to be modulated by electrotonic influ-
ences in small species, yet this finding remains to be confirmed in large mam-
malians.
The goal of the present study was to investigate APD differences between
epi- and endocardium depending on the pacing location and after a reduction
in intercellular coupling in sheep ventricles.
Optical mapping experiments were performed in coronary-perfused wedge
preparations from sheep left (LV; N=8) or right ventricles (RV; N=3). The
wedges were paced at 2Hz on either the endo- or epicardial surface. We also
investigated the effect of carbenoxolone (50 μM) in the RV experiments.
In the LV experiments, we observed a significant APD difference between
endo- (306.45±18.29ms) and epicardium (276.05±9.87ms) when pacing the
endocardium (P<0.01). However, this transmural heterogeneity was lost when
pacing the epicardium, with endocardial APDs of 284.10±25.67 ms vs
289.8±36.24 ms at the epicardium. A similar observation was made in the RV
with a significant increase in epicardial APD when pacing the epicardium
(230.17±11.32 ms) vs the endocardium (217.73±19.50 ms) (P<0.01). Upon
perfusion with carbenoxolone epicardial APDs significantly increased by 10%
(P<0.01) and the difference in epicardial APD between epicardial and endo-
cardial pacing was no longer significant.
In conclusion, we find that the epi- and endocardial APDs are modulated
by the activation sequence. Specifically, we observe a significant increase in
epicardial vs endocardial APD when pacing the epicardium in both the RV
and LV and an associated decrease in transmural APD heterogeneity. This
effect was abolished upon perfusion with carbenoxolone indicating a role for
electronic currents in modulating transmural APD heterogeneity.
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The CHA2DS2-VASc score estimates the risk of stroke in non-valvular
atrial fibrillation (AF). Nonetheless, there are limited data on the risk of
stroke/thromboembolic (TE) complications in AF patients with valvular heart
disease, other than those with valvular prosthesis or rheumatic mitral valve
disease.
Methods: Among 8962 patients with AF seen between 2000 and 2010,
patients were categorised into Group 1 “non valvular AF” (n=6851; 78%),
Group 2 “quasi valvular AF” ie. valve disease with neither rheumatic mitral
stenosis nor valve prothesis (n=1202; 13%) and Group 3 “valvular AF”
(n=909; 9%) using ESC AF guidelines definition.
Results: In group 2, 61% of the patients had mitral regurgitation (n=917,
non severe in 52%, severe in 9%), 24% had aortic regurgitation (n=414, non
severe in 22%, severe in 2%) and 32% had aortic stenosis (n=555, non
severe in 18%, severe in 14%). In group 3, 88% of the patients with valvular
AF had valve prostheses (n=797) and 14% had mitral stenosis (n=124).
After follow up of 884±1084 days, 715 stroke/TE events were recorded.
Group 2 was significantly older, had a higher CHA2DS2-VASc score and
had a higher risk of TE events (relative risk 1.39; 95%CI 1.14-1.69) com-
pared with Group 1. Severe valve disease was not associated with worse
prognosis for stroke/TE events (relative risk 1.12, 95%CI 0.78-1.61). In the
3 groups, stroke/TE risk increased with a higher CHA2DS2-VASc score.
Factors independently associated with increased risk of stroke/TE events
were older age (RR 1.02, 95%CI 1.01-1.03) and higher CHA2DS2-VASc
score (RR 1.33, 95%CI 1.23-1.45). The increased risk of stroke/TE events
in patients from Group 2 (compared to those from Group 1) did not reach
statistical significance in multivariate analysis.
Conclusions: In patients with AF, left-sided valvular heart disease
(excluding mitral stenosis and protheses) was associated with an increased risk
of stroke/TE events. A higher CHA2DS2-VASc score was the main driver of
these events.
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